Ruth Oliver

Examiner
DISC Type : cs

Vice President and Global Head of Quantitative Pharmacology and Translational Science at Takeda USA

United Kingdom

Overview

Ruth Oliver is a senior executive in the pharmaceutical industry, serving as the Vice President and Global Head of Quantitative Pharmacology and Translational Science at Takeda. With a Ph. D. from The University of Manchester, she has extensive experience leading global teams in pharmacometrics and drug development, previously spending 15 years at UCB.



Ruth is a published scientific author, having co-authored numerous research papers on pharmacokinetic and pharmacodynamic modeling for novel antibody drugs.

Personality Overview

Process Oriented

Overcautious

Tough To Convince

Being observant comes to them naturally.  The only way to convince them is by showing them examples and ample proof. They tend to have clarity about their needs and constraints, and are unlikely to over-promise.

Topics They Care About

Quantitative Pharmacology
Her entire career, including leadership roles at Takeda and UCB, has been focused on applying quantitative pharmacology, pharmacometrics, and DMPK to drug development.
Pharmacometric Modeling
She has co-authored multiple scientific papers on developing and applying population pharmacokinetic and exposure-response models for new drugs in clinical trials.
Translational Science
Her current role focuses on translational sciences, bridging the gap between preclinical drug discovery and clinical development to improve success rates.

Media Appearances

Ruth has no verified media appearances

Work History

4-2025
Vice President and Global Head of Quantitative Pharmacology and Translational Science at Takeda USA
6-2023 - 7-2025
VP, Global Head of QCP, Takeda at Takeda
4-2021 - 7-2023
Vice President and Head of Quantitative Pharmacology and DMPK at UCB
7-2011 - 4-2021
Global Head, Senior Director, Modelling and Simulation at UCB
4-2008 - 7-2011
Director at UCB

Education

1992 - 1995
Doctor of Philosophy (PhD) from The University of Manchester
1989 - 1992
Bsc(Jt Hons) from The University of Manchester

More Information

Social Presence :

Prographics :

Exp : 21 Location : United Kingdom Job Level : Senior Designation : Vice President and Global Head of Quantitative Pharmacology and Translational Science at Takeda USA
URL has been copied!

Insights For Selling To Ruth

During A Call Or A Meeting

DO's

  • Spend time addressing concerns around risk and change, they will have them even if they don't express them
  • Expect them to be vague in response to your questions, ask firmly and pointedly
  • First of all, focus on building their confidence by sharing examples, case studies etc.

DONT's

  • Don't use phrases like 'do not worry', 'i promise' etc.
  • Don't be very accepting if that is your natural style, stay firm
  • Avoid getting into storytelling mode, especially when they ask specific questions

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Ruth is

  • Low-risk, adoption by others are very important to them, followed by confidence in ROI.
  • Will you ever get a clear answer from Ruth

  • They don’t say no often, they push out the decisions or keep going around in circles.

Insights For Deal Planning

    How fast (or slow) will Ruth move?

  • They do not like to rush and therefore can be quite slow in their decision-making.
  • Can Ruth take some risk or not?

  • They have little risk-appetite and prefer to take measured decisions.

You And Ruth

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.